<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40702568</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1743-7075</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Nutrition &amp; metabolism</Title><ISOAbbreviation>Nutr Metab (Lond)</ISOAbbreviation></Journal><ArticleTitle>The effectiveness and safety of specific dietary supplements in modulating uric acid levels, oxidative stress, and lipid metabolism in patients: a network meta-analysis of 13 interventions.</ArticleTitle><Pagination><StartPage>80</StartPage><MedlinePgn>80</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">80</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12986-025-00977-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hyperuricemia and gout have garnered increasing attention as significant health concerns in recent years, often associated with damage to multiple bodily systems. Consequently, the reduction of uric acid levels has become particularly crucial. The utilization of dietary supplements presents potential adjunctive treatment options for individuals with gout. Certain dietary supplements are purported to aid in the reduction of uric acid levels and are highly preferred by patients due to their affordability, ease of use, and accessibility. The aim of this article was to compare the efficacy and safety of dietary supplements in modulating uric acid, oxidative stress, and lipid metabolism in patients with hyperuricemia or gout, using a comprehensive network meta-analysis (NMA) approach.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="METHODS">A comprehensive search was performed across both Chinese and English databases to identify randomized controlled trials (RCTs) examining the efficacy of dietary supplements in reducing uric acid levels. Network meta-analysis was conducted using Stata 16.0 software, while RevMan 5.3 software was employed to assess the quality of the literature and evaluate the risk of bias.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">A total of 30 RCTs, encompassing 44,972 patients, were conducted. The findings of the study indicated that folic acid (mean difference [MD]&#x2009;=&#x2009;-57.62&#xa0;&#x3bc;mol/L, 95% confidence interval [CI] [-107.14, -8.1]) and probiotics (MD&#x2009;=&#x2009;-42.52&#xa0;&#x3bc;mol/L, 95% CI [-81.95, -3.09]) significantly reduced uric acid levels compared to conventional therapy. Furthermore, Vitamin C (MD&#x2009;=&#x2009;-0.92 nmmol/ml, 95% CI [-1.54, -0.31]) and Vitamin E (MD&#x2009;=&#x2009;-1.05 nmmol/ml, 95% CI [-2.01, -0.1]) were effective in reducing oxidative stress-related malondialdehyde (MDA) levels. In terms of lipid metabolism improvement, DKB114 (MD&#x2009;=&#x2009;-0.45&#xa0;mmol/L, 95% CI [-0.9, -0.001]) and curcumin (MD&#x2009;=&#x2009;-0.54&#xa0;mmol/L, 95% CI [-0.89, -0.18]) demonstrated statistically significant reductions in low-density lipoprotein (LDL) levels. Analysis of subgroups revealed that administration of 500&#xa0;mg of vitamin C resulted in a significant reduce in uric acid levels when compared to conventional treatment (MD&#x2009;=&#x2009;&#x2009;-&#x2009;21.67&#xa0;&#x3bc;mol/L, 95% CI [-&#x2009;43.01,&#x2009;-&#x2009;0.33]), indicating statistically significant differences. The safety profile of all dietary supplements has generally been demonstrated to be favorable.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dietary supplements hold significant potential for managing gout and hyperuricemia, as well as improving patients' metabolic status. Future research should focus on larger-scale studies to further explore these findings.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ye</LastName><ForeName>Guancheng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Chunping</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiaojia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Jinying</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Cunxiang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingxuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yiwen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Luming</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hailong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China. wanghailong@bucm.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022YFC3501200 and 2022YFC3501203</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant><Grant><GrantID>DZMG-XZYY-23006</GrantID><Agency>Dongzhimen Hospital High level Traditional Chinese Medicine Hospital Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nutr Metab (Lond)</MedlineTA><NlmUniqueID>101231644</NlmUniqueID><ISSNLinking>1743-7075</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dietary supplements</Keyword><Keyword MajorTopicYN="N">Effectiveness</Keyword><Keyword MajorTopicYN="N">Gout</Keyword><Keyword MajorTopicYN="N">Hyperuricemia</Keyword><Keyword MajorTopicYN="N">Network meta-analysis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: All authors agreed to the publication of this manuscript. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40702568</ArticleId><ArticleId IdType="pmc">PMC12288254</ArticleId><ArticleId IdType="doi">10.1186/s12986-025-00977-2</ArticleId><ArticleId IdType="pii">10.1186/s12986-025-00977-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abeles AM. Hyperuricemia, gout, and cardiovascular disease: an update. Curr Rheumatol Rep. 2015;17(3):13. 10.1007/s11926-015-0495-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">25740704</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Ruiz F, Becker MA. Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease. Curr Med Res Opin. 2015;31(Suppl 2):9&#x2013;14. 10.1185/03007995.2015.1087980.</Citation><ArticleIdList><ArticleId IdType="pubmed">26414731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalal DI. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review. Curr Med Res Opin. 2016;32(11):1863&#x2013;9. 10.1080/03007995.2016.1218840.</Citation><ArticleIdList><ArticleId IdType="pubmed">27470664</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalbeth N, Merriman TR, Stamp LK. Gout Lancet. 2016;388(10055):2039&#x2013;52. 10.1016/S0140-6736(16)00346-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112094</ArticleId></ArticleIdList></Reference><Reference><Citation>Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, et al. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10(11):654&#x2013;61. 10.1038/nrrheum.2014.124.</Citation><ArticleIdList><ArticleId IdType="pubmed">25136785</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedder D, Walrabenstein W, Heslinga M, et al. Dietary interventions for gout and effect on cardiovascular risk factors: a systematic review. Nutrients. 2019;11(12):2955. 10.3390/nu11122955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6950134</ArticleId><ArticleId IdType="pubmed">31817107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang MA, Zhang Y, Terkeltaub R, et al. Effect of dietary and supplemental omega-3 polyunsaturated fatty acids on risk of recurrent gout flares. Arthritis Rheumatol. 2019;71(9):1580&#x2013;6. 10.1002/art.40896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717014</ArticleId><ArticleId IdType="pubmed">30908893</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumeliotis S, Roumeliotis A, Dounousi E, Eleftheriadis T, Liakopoulos V, et al. Dietary antioxidant supplements and uric acid in chronic kidney disease: a review. Nutrients. 2019;11(8):1911. 10.3390/nu11081911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6723425</ArticleId><ArticleId IdType="pubmed">31443225</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CS, Wen L, Yang F, Deng YC, Ji JH, Chen RJ, et al. Effects of dietary supplements on patients with osteoarthritis: a systematic review and network meta-analysis. J Integr Med. 2025;S2095&#x2013;4964(25):00053&#x2013;6. 10.1016/j.joim.2025.04.008.</Citation><ArticleIdList><ArticleId IdType="pubmed">40425393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawska A, Bromage S, Simoes JA, Zupkauskien&#x117; J, McMahon N, Zalewski P, et al. The impact of dietary supplements on blood pressure in older adults: a network meta-analysis of randomized controlled trials. Heliyon. 2024;10(4):e25615. 10.1016/j.heliyon.2024.e25615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10877265</ArticleId><ArticleId IdType="pubmed">38380006</ArticleId></ArticleIdList></Reference><Reference><Citation>Osadnik T, Go&#x142;awski M, Lewandowski P, Morze J, Osadnik K, Pawlas N, et al. A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. Pharmacol Res. 2022;183:106402. 10.1016/j.phrs.2022.106402.</Citation><ArticleIdList><ArticleId IdType="pubmed">35988871</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1&#x2013;11. 10.1186/s13643-021-01626-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from: http://handbook-5-1.cochrane.org/. Accessed 27 Dec 2024.</Citation></Reference><Reference><Citation>Xie H, Ji L, Chen M, Chen YQ, Huang CY, Sun JQ. Effect of tea polyphenols and vitamin c intervention on patients with hyperuricemia and dyslipidemia. Acta Nutr Sin. 2010;32(6):575&#x2013;8. 10.13325/j.cnki.acta.nutr.sin.2010.06.027.</Citation></Reference><Reference><Citation>Jiang S, Zhang DD. Clinical observation of tea polyphenols and vitaminc intervention on patients with hyperuricemia and dyslipidemia. Hebei Med. 2017;23(10):1724&#x2013;9. 10.3969/j.issn.1006-6233.2017.10.042.</Citation></Reference><Reference><Citation>Zeng XG, Huang L, Liao YP, Qin ZY, Qiu ZP. Effect of oral vitamin C tablets on serum uric acid level in patients with hypertension complicated with hyperuricemia. Chin Fore Med Treat. 2016;35(27):115&#x2013;7. 10.16662/j.cnki.1674-0742.2016.27.115.</Citation></Reference><Reference><Citation>Shao JH, Yuan F, Chen CY, Zhou HJ, Jiang F, Zhou YY, et al. Analysis of the uric acid lowering effect of febuxostat combined with medicinal charcoal and vitamin C in the treatment of chronic gout. Zhejiang Med J. 2017;39(11):925&#x2013;7.</Citation></Reference><Reference><Citation>Zeng XG, Huang L, Liao YP, Qin ZY, Qiu ZP. Clinical observation of oral vitamin C treatment for hyperuricemia. Chin J of Clin Rational Drug Use. 2016;9(27):57&#x2013;9. 10.15887/j.cnki.13-1389/r.2016.27.027.</Citation></Reference><Reference><Citation>Chen HY, Zhou SC, Chen WQ, Long JW. Effect of vitamin C on recurrence of gouty arthritis after first attack. Med Innovation Chin. 2019;16(2):37&#x2013;41. 10.3969/j.issn.1674-4985.2019.02.010.</Citation></Reference><Reference><Citation>Hoydonck PGAV, Schouten EG, Manuel-Y-Keenoy B, Campenhout AV, Hoppenbrouwers KPM, Temme EHM. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? Eur J Clin Nutr. 2004;58(12):1587&#x2013;93. 10.1038/sj.ejcn.1601990.</Citation><ArticleIdList><ArticleId IdType="pubmed">15127090</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Aal AA, El-Ghffar EAA, Ghali AA, Zughbur MR, Sirdah MM. The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: a single-blinded randomized controlled clinical trial. Diabetes Metab Syndr. 2018;12(4):483&#x2013;9. 10.1016/j.dsx.2018.03.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">29571976</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H, Feng DF, Wang YK, Dong ZX, Chen Q, Zhang LH, et al. Effect of oral vitamin C supplementation on high-altitude hyperuricemia in young men initially migrating to high altitude: a pilot study. High Alt Med Biol. 2018;19(4):373&#x2013;81. 10.1089/ham.2018.0058.</Citation><ArticleIdList><ArticleId IdType="pubmed">30358417</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum. 2005;52(6):1843&#x2013;7. 10.1002/art.21105.</Citation><ArticleIdList><ArticleId IdType="pubmed">15934094</ArticleId></ArticleIdList></Reference><Reference><Citation>Juraschek SP, Gaziano JM, Glynn RJ, Gomelskaya N, Bubes VY, Buring JE, et al. Effects of vitamin C supplementation on gout risk: results from the Physicians&#x2019; Health Study II trial. Am J Clin Nutr. 2022;116(3):812&#x2013;9. 10.1093/ajcn/nqac140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9437983</ArticleId><ArticleId IdType="pubmed">35575611</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimitphong H, Saetung S, Chailurkit LO, Chanprasertyothin S, Ongphiphadhanakul B. Vitamin D supplementation is associated with serum uric acid concentration in patients with prediabetes and hyperuricemia. J Clin Transl Endocrinol. 2021;24:100255. 10.1016/j.jcte.2021.100255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8054183</ArticleId><ArticleId IdType="pubmed">33898272</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YH, Kim DH, Lee JS, Jeong HI, Lee KW, Kang TH. A 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial for evaluation of the efficacy and safety of DKB114 on reduction of uric acid in serum. Nutrients. 2020;12(12):3794. 10.3390/nu12123794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7763673</ArticleId><ArticleId IdType="pubmed">33322063</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima S, Shiiya S, Nakamura Y. Serum uric acid-lowering effects of combined glycine and tryptophan treatments in subjects with mild hyperuricemia: a randomized, double-blind, placebo-controlled, crossover study. Nutrients. 2019;11(3):564. 10.3390/nu11030564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6471320</ArticleId><ArticleId IdType="pubmed">30845731</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Williamson G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial. Br J Nutr. 2016;115(5):800&#x2013;6. 10.1017/S0007114515005310.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bupparenoo P, Pakchotanon R, Narongroeknawin P, Asavatanabodee P, Chaiamnuay S. Effect of curcumin on serum urate in asymptomatic hyperuricemia: a randomized placebo-controlled trial. J Diet Suppl. 2021;18(3):248&#x2013;60. 10.1080/19390211.2020.1757798.</Citation><ArticleIdList><ArticleId IdType="pubmed">32420786</ArticleId></ArticleIdList></Reference><Reference><Citation>Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mend&#xed;a LE, Sahebkar A. Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol. 2016;68(3):223&#x2013;9. 10.1097/FJC.0000000000000406.</Citation><ArticleIdList><ArticleId IdType="pubmed">27124606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamshed H, Gilani AUH, Sultan FAT, Amin F, Arslan J, Ghani S, et al. Almond supplementation reduces serum uric acid in coronary artery disease patients: a randomized controlled trial. Nutr J. 2016;15(1):77. 10.1186/s12937-016-0195-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4991057</ArticleId><ArticleId IdType="pubmed">27543277</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin XH, Li YB, He ML, Tang GF, Yin DL, Liang M, et al. Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT). Am J Clin Nutr. 2017;105(4):882&#x2013;9. 10.3945/ajcn.116.143131.</Citation><ArticleIdList><ArticleId IdType="pubmed">28148501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou SZ. The effect of folic acid combined with rosuvastatin on serum uric acid and CysC levels in patients with primary hypertension. Clin Med. 2020;40(8):91&#x2013;3. 10.19528/j.issn.1003-3548.2020.08.036.</Citation></Reference><Reference><Citation>Qu Y. Effects of vitamin B12, folic acid and shagliptin on serum cystatin C, uric acid and oxidative stress in patients with type 2 diabetes. Chin J Gerontol. 2016;36(19):4771&#x2013;2. 10.3969/j.issn.1005-9202.2016.19.045.</Citation></Reference><Reference><Citation>Lu XZ, Wang F. The effect of compound vitamins on serum uric acid levels in asymptomatic hyperuricemia patients. Lab Med Clin. 2015;12(22):3406&#x2013;7. 10.3969/j.issn.1672-9455.2015.22.045.</Citation></Reference><Reference><Citation>He SQ, Xiong QQ, Tian C, Li L, Zhao J, Lin XC, et al. Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients. Eur J Nutr. 2022;61(2):665&#x2013;77. 10.1007/s00394-021-02669-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">34491388</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and/or gout: a randomised, double-blind, placebo-controlled study. Mod Rheumatol. 2019;29(1):146&#x2013;50. 10.1080/14397595.2018.1442183.</Citation><ArticleIdList><ArticleId IdType="pubmed">29446654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan YP, Wang GF, Li X, Zhu XS, Tong FJ. Clinical observation of the combination of Clostridium butyricum viable tablets and febuxostat in the treatment of non-acute gout. Zhejiang J Integr Trad Chin West Med. 2020;30(5):385&#x2013;8.</Citation></Reference><Reference><Citation>Wang P, Xu J. Efficacy of live combined&#xa0;Bifidobacterium,&#xa0;Lactobacillus&#xa0;and&#xa0;Enterococcus&#xa0;capsules combined with febuxostat in the treatment of patients with intermittent gout attack. Eval Anal Drug-Use Hosp Chin. 2022;22(1):47&#x2013;50. 10.14009/j.issn.1672-2124.2022.01.010.</Citation></Reference><Reference><Citation>Gonzalez DE, Kendra JA, Dickerson BL, Yoo C, Ko J, McAngus K, et al. Effects of acute and one-week supplementation with Montmorency tart cherry powder on food-induced uremic response and markers of health: a proof-of-concept study. Nutrients. 2024;16(19):3391. 10.3390/nu16193391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11478512</ArticleId><ArticleId IdType="pubmed">39408358</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin KR, Coles KM. Consumption of 100% tart cherry juice reduces serum urate in overweight and obese adults. Curr Dev Nutr. 2019;3(5):nzz011. 10.1093/cdn/nzz011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6483050</ArticleId><ArticleId IdType="pubmed">31037275</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Green C, Morgan S, Willig AL, Darnell B, Saag KG, et al. A randomized internet-based pilot feasibility and planning study of cherry extract and diet modification in gout. J Clin Rheumatol. 2020;26(4):147&#x2013;56. 10.1097/RHU.0000000000001004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8664374</ArticleId><ArticleId IdType="pubmed">32453288</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamp LK, Chapman P, Frampton C, Duffull SB, Drake J, Zhang YQ, et al. Lack of effect of tart cherry concentrate dose on serum urate in people with gout. Rheumatology (Oxford). 2020;59(9):2374&#x2013;80. 10.1093/rheumatology/kez606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10687352</ArticleId><ArticleId IdType="pubmed">31891407</ArticleId></ArticleIdList></Reference><Reference><Citation>Juraschek SP, Iii ERM, Gelber AC. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials. Arthritis Care Res. 2011;63(9):1295&#x2013;306. 10.1002/acr.20519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169708</ArticleId><ArticleId IdType="pubmed">21671418</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng LT, Yang TJ, Yang KL, Yu GP, Li J, Xiang W, et al. Efficacy and safety of curcumin and Curcuma longa extract in the treatment of arthritis: a systematic review and meta-analysis of randomized controlled trial. Front Immunol. 2022;13:891822. 10.3389/fimmu.2022.891822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353077</ArticleId><ArticleId IdType="pubmed">35935936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo YW, Hsieh SH, Chen JF, Liu CR, Chen CW, Huang YF, et al. Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats. PEER J. 2021;9:e11209. 10.7717/peerj.11209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8101448</ArticleId><ArticleId IdType="pubmed">33986988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahebkar A. A systematic review and meta - analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin Nutr. 2014;33(3):406&#x2013;14. 10.1016/j.clnu.2013.09.012.</Citation><ArticleIdList><ArticleId IdType="pubmed">24139527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruoff G, Edwards NL. Overview of serum uric acid treatment targets in gout: why less than 6 mg/dL? Postgrad Med. 2016;128(7):706&#x2013;15. 10.1080/00325481.2016.1221732.</Citation><ArticleIdList><ArticleId IdType="pubmed">27558643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz FP, Richette P, Stack AG, et al. Failure to reach uric acid target of &lt;0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality. RMD Open. 2019;5(2):e001015. 10.1136/rmdopen-2019-001015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6803010</ArticleId><ArticleId IdType="pubmed">31673414</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzezi&#x144;ska O, Styrzy&#x144;ski F, Makowska J, Walczak K. Role of vitamin C in prophylaxis and treatment of gout - a literature review. Nutrients. 2021;13(2):701. 10.3390/nu13020701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7926958</ArticleId><ArticleId IdType="pubmed">33671646</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumeliotis S, Roumeliotis A, Dounousi E, Eleftheriadis T, Liakopoulos V. Dietary antioxidant supplements and uric acid in chronic kidney disease: a review. Nutrients. 2019;11(8):1911. 10.3390/nu11081911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6723425</ArticleId><ArticleId IdType="pubmed">31443225</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzezi&#x144;ska O, Styrzy&#x144;ski F, Makowska J, Walczak K. Role of vitamin C in prophylaxis and treatment of gout - a literature review. Nutrients. 2021;13(2):701. 10.3390/nu13020701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7926958</ArticleId><ArticleId IdType="pubmed">33671646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y, Liu Y, Li S. Association between dietary vitamin C intake and gout among American adults. Front Immunol. 2024;15:1431323. 10.3389/fimmu.2024.1431323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11437527</ArticleId><ArticleId IdType="pubmed">39346908</ArticleId></ArticleIdList></Reference><Reference><Citation>Juraschek SP, Gaziano JM, Glynn RJ, Gomelskaya N, Bubes VY, Buring JE, et al. Effects of vitamin C supplementation on gout risk: results from the Physicians&#x2019; Health Study II trial. Am J Clin Nutr. 2022;116(3):812&#x2013;9. 10.1093/ajcn/nqac140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9437983</ArticleId><ArticleId IdType="pubmed">35575611</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamshed H, Gilani AH. Almonds inhibit dyslipidemia and vascular dysfunction in rats through multiple pathways. J Nutr. 2014;144(11):1768&#x2013;74. 10.3945/jn.114.198721.</Citation><ArticleIdList><ArticleId IdType="pubmed">25332475</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottone A, Montoro P, Masullo M, Pizza C, Piacente S. Metabolite profiling and antioxidant activity of the polar fraction of Italian almonds (Toritto and Avola): Analysis of seeds, skins, and blanching water. J Pharm Biomed Anal. 2020;190:113518. 10.1016/j.jpba.2020.113518.</Citation><ArticleIdList><ArticleId IdType="pubmed">32798920</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhol NK, Bhanjadeo MM, Singh AK, Dash UC, Ojha RR, Majhi S, et al. The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti - cytokine compounds. Biomed Pharmacother. 2024;178:117177. 10.1016/j.biopha.2024.117177.</Citation><ArticleIdList><ArticleId IdType="pubmed">39053423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia XD, Li N, Zhang W, Zhang X, Lapsley K, Huang GW, et al. A pilot study on the effects of almond consumption on DNA damage and oxidative stress in smokers. Nutr Cancer. 2006;54(2):179&#x2013;83. 10.1207/s15327914nc5402_4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16898862</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheepers LE. Folic acid: the solution for treating asymptomatic hyperuricemia? Am J Clin Nutr. 2017;105(4):775&#x2013;6. 10.3945/ajcn.117.154294.</Citation><ArticleIdList><ArticleId IdType="pubmed">28298395</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Zhang XQ, Zheng X, Gao JR, Shang MF, Xu JH, et al. Folic acid protects against hyperuricemia in C57BL/6J mice via ameliorating gut - kidney axis dysfunction. J Agric Food Chem. 2022;70(50):15787&#x2013;803. 10.1021/acs.jafc.2c06297.</Citation><ArticleIdList><ArticleId IdType="pubmed">36473110</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin XH, Li YB, He ML, Tang GF, Yin DL, Liang M, et al. Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT). Am J Clin Nutr. 2017;105(4):882&#x2013;9. 10.3945/ajcn.116.143131.</Citation><ArticleIdList><ArticleId IdType="pubmed">28148501</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng YL, Tain YL, Lee CT, Yang YH, Huang YB, Wen YH, et al. Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease. Sci Rep. 2020;10(1):10734. 10.1038/s41598-020-67026-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7329906</ArticleId><ArticleId IdType="pubmed">32612180</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezer S, Karakan S, Atesagaoglu B, Acar FNO. Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia. Saudi J Kidney Dis Transpl. 2014;25(2):316&#x2013;20. 10.4103/1319-2442.128520.</Citation><ArticleIdList><ArticleId IdType="pubmed">24625997</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamil Y, Alameddine D, Iskandarani ME, Agrawal A, Arockiam AD, Haroun E, et al. Cardiovascular Outcomes of Uric Acid Lowering Medications: A Meta-Analysis. Curr Cardiol Rep. 2024;26(12):1427&#x2013;37. 10.1007/s11886-024-02138-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">39352584</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZQ, Sun X, Liu ZB, Zhang T, Zhang LL, Wu CJ. Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity. J Pharm Pharmacol. 2022;74(7):919&#x2013;29. 10.1093/jpp/rgac024.</Citation><ArticleIdList><ArticleId IdType="pubmed">35640306</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada N, Saito C, Murayama-Chiba Y, Kano H, Asami Y, Itoh H. Lactobacillus gasseri PA - 3 utilizes the purines GMP and guanosine and decreases their absorption in rats. Nucleosides Nucleotides Nucleic Acids. 2018;37(5):307&#x2013;15. 10.1080/15257770.2018.1454949.</Citation><ArticleIdList><ArticleId IdType="pubmed">29723107</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Hu P, Jin MP, Sun WQ, Wu JJ, Tang YY, et al. Compound probiotics alleviate hyperuricemia-induced renal injury via restoring gut microbiota and metabolism. BMC Microbiol. 2025;25(1):280. 10.1186/s12866-025-04012-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12060558</ArticleId><ArticleId IdType="pubmed">40335932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZH, Huang YM, Yang T, Song LQ, Xiao YC, Chen YL, et al. Lactococcus cremoris&#xa0;D2022 alleviates hyperuricemia and suppresses renal inflammation&#xa0;via&#xa0;potential gut-kidney axis. Food Funct. 2024;15(11):6015&#x2013;27. 10.1039/d4fo00118d.</Citation><ArticleIdList><ArticleId IdType="pubmed">38747642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasti AN, Synodinou KD, Pyrousis IA, Nikolaki MD, Triantafyllou KD. Probiotics regulating inflammation via NLRP3 inflammasome modulation: a potential therapeutic approach for COVID-19. Microorganisms. 2021;9(11):2376. 10.3390/microorganisms9112376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8624812</ArticleId><ArticleId IdType="pubmed">34835501</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu ZD, Yue LL, Yang ZJ, Wang YS, Wang ZH, Zhou F, et al. Impairment of intestinal barrier associated with the alternation of intestinal flora and its metabolites in cow&#x2019;s milk protein allergy. Microb Pathog. 2023;183:106329. 10.1016/j.micpath.2023.106329.</Citation><ArticleIdList><ArticleId IdType="pubmed">37659726</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun XW, Wen J, Guan BS, Li JL, Luo JC, Li J, et al. Folic acid and zinc improve hyperuricemia by altering the gut microbiota of rats with high - purine diet - induced hyperuricemia. Front Microbiol. 2022;13:907952. 10.3389/fmicb.2022.907952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9372534</ArticleId><ArticleId IdType="pubmed">35966674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YS, Kim SH, Yuk HJ, Kim DS. DKB114, A Mixture of Chrysanthemum Indicum Linne Flower and Cinnamomum Cassia (L.) J. Presl bark extracts, improves hyperuricemia through inhibition of xanthine oxidase activity and increasing urine excretion. Nutrients. 2018;10(10):1381. 10.3390/nu10101381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213378</ArticleId><ArticleId IdType="pubmed">30274153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirakosyan A, Gutierrez E, Solano BR, Seymour EM, Bolling SF. The inhibitory potential of Montmorency tart cherry on key enzymes relevant to type 2 diabetes and cardiovascular disease. Food Chem. 2018;252:142&#x2013;6. 10.1016/j.foodchem.2018.01.084.</Citation><ArticleIdList><ArticleId IdType="pubmed">29478524</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Peng H, Ma QH, Zhou XH, Xu WX, Huang L, et al. Associations of non - high density lipoprotein cholesterol and traditional blood lipid profiles with hyperuricemia among middle - aged and elderly Chinese people: a community - based cross - sectional study. Lipids Health Dis. 2014;13:117. 10.1186/1476-511X-13-117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4115491</ArticleId><ArticleId IdType="pubmed">25052552</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBoer MD, Dong LL, Gurka MJ. Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999&#x2013;2006. Metabolism. 2012;61(4):554&#x2013;61. 10.1016/j.metabol.2011.09.003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3262070</ArticleId><ArticleId IdType="pubmed">22000606</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad M, Matteson EL, Herrmann J, Gulati R, Rihal CS, Lerman LO, et al. Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women. Hypertension. 2017;69(2):236&#x2013;42. 10.1161/HYPERTENSIONAHA.116.08436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233565</ArticleId><ArticleId IdType="pubmed">27993955</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu XL, Wang HF, Guo DD, Man XF, Liu J, Li JY, et al. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy. Ren Fail. 2021;43(1):1063&#x2013;75. 10.1080/0886022X.2021.1944875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8253186</ArticleId><ArticleId IdType="pubmed">34187292</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeill SH. Inclusion of red meat in healthful dietary patterns. Meat Sci. 2014;98(3):452&#x2013;60. 10.1016/j.meatsci.2014.06.028.</Citation><ArticleIdList><ArticleId IdType="pubmed">25034452</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong SZ, Zou L, Zhang YN, Zhang GT, Li XX, Li MJ, et al. Determination of purine contents in different parts of pork and beef by high performance liquid chromatography. Food Chem. 2015;170:303&#x2013;7. 10.1016/j.foodchem.2014.08.059.</Citation><ArticleIdList><ArticleId IdType="pubmed">25306349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam HM, Remais J, Fung MC, Xu L, Sun SSM. Food supply and food safety issues in China. Lancet. 2013;381(9882):2044&#x2013;53. 10.1016/S0140-6736(13)60776-X.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3888022</ArticleId><ArticleId IdType="pubmed">23746904</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang BY, Mo ZN, Wu C, Yang HD, Yang XB, He YF, et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genomics. 2014;7:10. 10.1186/1755-8794-7-10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3923000</ArticleId><ArticleId IdType="pubmed">24513273</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Jiang F, Zhang R, Tang SS, Chen M, Peng DF, et al. Serum uric acid levels are associated with polymorphisms in the SLC2A9, SF1, and GCKR genes in a Chinese population. Acta Pharmacol Sin. 2014;35(11):1421&#x2013;7. 10.1038/aps.2014.87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4220079</ArticleId><ArticleId IdType="pubmed">25283508</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>